Marseille-Kliniken AG
Marseille-Kliniken AG:
Marseille-Kliniken AG / Key word(s): Final Results 30.11.2010 07:23 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- * Revenues of EUR 240.7 million (Previous year: EUR 235.5 million) * EBIT EUR 4.3 million (Previous year: EUR -6,8 million) * Sale of REHA clinics effective 30th April 2010 * Business focus placed on inpatient care and assisted living Based on audited figures for the 2009/2010 financial year (01.07.2009 - 30.06.2010) the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) increased its operating revenues by 2.2%, or EUR 5.2 million, to EUR 240.7 million (previous year: 235.5 million). Consolidated net income was increased to EUR +0.6 million following EUR -13.5 million for the previous year. Per share - on the basis of 12,150,000 no par value shares - this amounts to income of EUR +0.05 after EUR -1.12 for the previous year. EBITDAR (Earnings before interest, taxes, depreciation, amortization and leasing expenses) rose to EUR 75.1 million following EUR 50.6 million for the previous year. At EUR 25.3 million, EBITDA was noticeably higher than in the previous year (EUR 3.6 million) and EBIT including other taxes rose to EUR 4.3 million (previous year EUR -6.8 million). EBT amounted to EUR 0.6 million following EUR -12.1 million for the previous year). The EBITDAR margin improved to 31.4% following 21.5% in the previous year; at 10.8%, the EBITDA margin was significantly higher than that of the previous year at 1.5% and the EBIT margin rose significantly from -2.9% to +1.8%. Equity capital, plus 84.2% of the accrued investment grants (previous year: 84.2%), amounted to EUR 61.1 million following EUR 62.6 million for the previous year. This resulted in an equity ratio of 30.9% (previous year 27.6%). As at 30th June 2010, the number of beds in the 62 care facilities amounted to 8.370. On the reporting date for the previous year, there were 7,750 beds available in 58 care facilities. The increase in the number of beds in care facilities by 608 resulted from facility openings in Oberhausen, Bremerhaven, Waldkirch and Gera (assisted living). At 92.2% (without the expansion facilities), the utilisation ratio within the group was slightly below that of the previous year. With the sale of the rehabilitation clinics, effective as at 30th April 2010, and the termination of its emergency hospital activities, the Marseille-Kliniken AG has cleared the way for placing the company's focus on its core activities of inpatient care and assisted living. In addition, a comprehensive cost-cutting programme related to personnel and materials costs created conditions for sustainable increases in profitability. The Marseille-Kliniken AG expects further stabilisation in net income for the group for the 2010/2011 financial year. Marseille-Kliniken AG Dr. Thomas Klaue CFO Sportallee 1 22335 Hamburg Tel.: +49 (0) 40 / 51459-302 Fax: +49 (0) 40 / 51459-737 www.marseille-kliniken.de HFN Kommunikation GmbH Daniela Münster Investor Relations für die Marseille-Kliniken AG Hanauer Landstraße 161-173 60314 Frankfurt Tel. no.: 49, 0, 69, 923186, 20 Fax, +49 (0) 69 923186-20 www.hfn.de 30.11.2010 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Marseille-Kliniken AG Sportallee 1 22335 Hamburg Deutschland Phone: +49 (0)405 14 59-0 Fax: +49 (0)405 14 59-7 37 E-mail: info@marseille-kliniken.com Internet: www.marseille-kliniken.de ISIN: DE0007783003 WKN: 778300 Listed: Regulierter Markt in Frankfurt (Prime Standard), Hamburg; Freiverkehr in München, Berlin, Düsseldorf, Hannover, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found